Fresh analysis reveals that people who come off blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who halt conventional lifestyle programs.
Findings released in a prominent health publication demonstrates that while obese people often shed substantial amounts of their total mass while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month once they quit.
"Individuals buying these drugs need to be informed of the risk of rapid weight regain when the therapy concludes," stated expert Dr. Susan Jebb.
Such speed of regain suggests a reversion to pre-treatment mass within about one and a half years.
Comparing Therapies
The research, which examined 37 of studies involving thousands of participants, contrasted the results of the injectable medications with conventional dieting.
The team note that people who lose weight through lifestyle changes alone usually experience a slower weight regain—approximately 100 grams monthly—after stopping.
Understanding the Rapid Regain
Nutrition scientists propose the mechanism of the injections explains the heightened regain.
The injections copy a natural hormone called glucagon-like peptide-1, which controls appetite.
"Sustained high doses of the hormone levels far above than normal could lead to the system to produce less of its endogenous GLP-1, and could lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this medication means appetite is uncontrolled, making overeating much more probable."
An Ongoing Disease?
The NHS recommend the jabs for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Professionals contend that, considering the high risk of relapse, the treatment should be considered life-long.
This perspective is supported by drug manufacturers, who state that the results "underscore the chronic character of obesity," akin to managing diseases like hypertension.
User Accounts
Individuals who have discontinued the jabs describe a powerful resurgence of appetite.
"It was like a trigger that goes on and you're instantly ravenous," described a patient.
This challenge is worsened if users have not adopted lasting lifestyle or habit modifications during therapy.
Widespread Adoption
Figures suggest that millions of people in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial.
- Use is greater among females than men.
- The middle-aged age group shows the greatest level of interest.
- A large proportion obtain the drugs through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while the jabs are effective tools for shedding pounds, they are not a permanent solution and lasting health benefits likely depends on ongoing lifestyle changes.
